Pharmaceutical Packaging: United States
This report forecasts to 2023 US pharmaceutical packaging demand in nominal US dollars at the manufacturer level. Total demand is segmented by product in terms of: plastic bottles; blister packaging; parenteral containers; prefillable inhalers; other primary containers such as pouches, medication tubes, and intravenous (IV) containers; closures; secondary containers; packaging accessories; and labels.
To illustrate historical trends, total demand is provided in annual series from 2008 to 2018; the various segments are reported at five-year intervals for 2008, 2013, and 2018.
For purposes of this report, pharmaceutical packaging product demand is defined as the value of finished containers, closures, and accessories sold by merchant companies and produced or assembled internally by pharmaceutical manufacturers and contract packaging firms.
US statistics for pharmaceutical packaging products include sales and production activities in Puerto Rico. Most major multinational drug makers operate one or more production facilities and consume a significant volume of packaging in that territory. In 2016, Puerto Rico accounted for approximately 45% of the value of US pharmaceutical shipments and a comparable level of pharmaceutical packaging demand.
Key macroeconomic indicators are also provided with quantified trends. Other various topics, including profiles of pertinent leading companies, are covered in this report. A full outline of report items by page is available in the Table of Contents.
Related NAICS Codes:
322211 Corrugated and solid fiber box manufacturing
322212 Folding paperboard box manufacturing
326111 Plastics bag and pouch manufacturing
326112 Plastics packaging film and sheet (including laminated) manufacturing
326160 Plastics bottle manufacturing
327213 Glass container manufacturing
Back to Top